Clinical studies recruiting near Westminster

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · William E Kahlert Regional Cancer Center/Sinai Hospital · NRG Oncology · NCT05624996 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Alfasigma S.p.A. · NCT06865417 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · Relay Therapeutics, Inc. · NCT06789913 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 COlorectal BReath Analysis (COBRA2)
Phase N/A · Imperial College London · NCT05844514 Post-Market Study to Assess iTind Safety in Comparison to UroLift
NA · Olympus Corporation of the Americas · NCT04757116 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Saint Anthony North Hospital · Alliance for Clinical Trials in Oncology · NCT07091617 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Janssen Research & Development, LLC · NCT07499232 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · William E Kahlert Regional Cancer Center/Sinai Hospital · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Saint Anthony North Hospital · Alliance for Clinical Trials in Oncology · NCT06632327 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Centura Health - St. Anthony North Health Campus ( Site 0189 · Merck Sharp & Dohme LLC · NCT06623422 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Saint Anthony North Hospital · Alliance for Clinical Trials in Oncology · NCT06876714 Endometrioma Sclerotherapy and Ovarian Preservation
NA · Chelsea and Westminster NHS Foundation Trust · NCT06775769 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Saint Anthony North Hospital · Canadian Cancer Trials Group · NCT06592924 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0472 · Bristol-Myers Squibb · NCT06561386 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · William E Kahlert Regional Cancer Center/Sinai Hospital · NRG Oncology · NCT06748222 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Saint Anthony North Hospital · Alliance for Clinical Trials in Oncology · NCT04242095 A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Phase 2 · Imperial College London · NCT04319367 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · William E Kahlert Regional Cancer Center/Sinai Hospital · National Cancer Institute (NCI) · NCT05256225 Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · University of Leeds · NCT04102930 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Saint Anthony North Hospital · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Saint Anthony North Hospital · NRG Oncology · NCT04852887 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Boehringer Ingelheim · NCT06632457 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Saint Anthony North Hospital · Alliance for Clinical Trials in Oncology · NCT05677490 Shared Decision-making and Antimicrobial Stewardship in Secondary Care
Phase N/A · Royal Cornwall Hospitals Trust · NCT06605820 The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · University of Leicester · NCT04204915 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · William E Kahlert Regional Cancer Center/Sinai Hospital · National Cancer Institute (NCI) · NCT06058377 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Saint Anthony North Hospital · NRG Oncology · NCT05080673 Effect of Obesity, Diabetes and Bariatric Surgery on Pregnancy Outcomes
Phase N/A · Chelsea and Westminster NHS Foundation Trust · NCT05753124 SCAD : a Registry of Spontaneous Coronary Artery Dissection
Phase N/A · European Society of Cardiology · NCT06601270

Look up another city

Look up another condition